HEALTH● LOWJul 14 · Jul 14, 2026, 8:58 PM
Celcuity gains approval of breast cancer therapy gedatolisib
Seeking Alpha Tech
Celcuity has received approval for its breast cancer therapy, gedatolisib. This represents a new development in cancer treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH12m agoCDC deputy director to leave administration after 4 monthsThe HillHEALTH33m agoNigeria records 43,000 snakebites, 2,500 deaths yearlyVanguard NigeriaHEALTH1h agoEbola: NCDC defends patient’s evacuation, rejects claims of no confidenceVanguard NigeriaHEALTH1h agoCDC's chief medical officer resigns after being hired in AprilABC News